170 related articles for article (PubMed ID: 10490419)
1. rhDNase in cystic fibrosis.
Tyrrell JC; Lewis PA; Sheldon CD; Connett G
Thorax; 1999 Aug; 54(8):752. PubMed ID: 10490419
[No Abstract] [Full Text] [Related]
2. Recombinant human DNase (rhDNase) in cystic fibrosis: is it cost effective?
Conway SP
Arch Dis Child; 1997 Jul; 77(1):1-3. PubMed ID: 9279142
[No Abstract] [Full Text] [Related]
3. rhDNase therapy for the treatment of cystic fibrosis patients with mild to moderate lung disease.
Christopher F; Chase D; Stein K; Milne R
J Clin Pharm Ther; 1999 Dec; 24(6):415-26. PubMed ID: 10651974
[TBL] [Abstract][Full Text] [Related]
4. Dornase alpha and survival of patients with cystic fibrosis.
McIntyre AM
Hosp Med; 1999 Oct; 60(10):736-9. PubMed ID: 10656067
[TBL] [Abstract][Full Text] [Related]
5. A multinational economic evaluation of rhDNase in the treatment of cystic fibrosis.
Menzin J; Oster G; Davies L; Drummond MF; Greiner W; Lucioni C; Merot JL; Rossi F; vd Schulenburg JG; Souêtre E
Int J Technol Assess Health Care; 1996; 12(1):52-61. PubMed ID: 8690562
[TBL] [Abstract][Full Text] [Related]
6. rhDNase in cystic fibrosis.
Range SP; Knox AJ
Thorax; 1995 Apr; 50(4):321-2. PubMed ID: 7785000
[No Abstract] [Full Text] [Related]
7. Where we are now with rhDNase.
Geddes DM; Shah PL
Lancet; 1999 May; 353(9166):1727. PubMed ID: 10347981
[No Abstract] [Full Text] [Related]
8. Aerosolized dornase alpha (rhDNase) in cystic fibrosis.
Bates RD; Nahata MC
J Clin Pharm Ther; 1995 Dec; 20(6):313-5. PubMed ID: 8847368
[TBL] [Abstract][Full Text] [Related]
9. Comment: cost of rhDNase in cystic fibrosis.
Bates RD; Nahata MC
Ann Pharmacother; 1995 Oct; 29(10):1051. PubMed ID: 8845551
[No Abstract] [Full Text] [Related]
10. Comment: cost of rhDNase in cystic fibrosis.
Marra CA; Carleton BC; Basmadjian D; Levine M; McKerrow R
Ann Pharmacother; 1995 Oct; 29(10):1050-1. PubMed ID: 8845550
[No Abstract] [Full Text] [Related]
11. The role of dornase alfa in the treatment of cystic fibrosis.
Cramer GW; Bosso JA
Ann Pharmacother; 1996 Jun; 30(6):656-61. PubMed ID: 8792953
[TBL] [Abstract][Full Text] [Related]
12. Dornase alfa: a new option in the management of cystic fibrosis.
Witt DM; Anderson L
Pharmacotherapy; 1996; 16(1):40-8. PubMed ID: 8700791
[TBL] [Abstract][Full Text] [Related]
13. [New pharmacological approaches: rhDNase].
Tournier G; Sardet A; Grosskopf C; Baculard A; Delaisi B
Rev Pneumol Clin; 1995; 51(3):193-200. PubMed ID: 7569583
[TBL] [Abstract][Full Text] [Related]
14. Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.
Spencer DA
Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S89-91. PubMed ID: 9155860
[No Abstract] [Full Text] [Related]
15. The clinical use of rhDNAse.
Davies J; Trindale M; Wallis C; Rosenthal M; Bush A
Pediatr Pulmonol Suppl; 1997; 16():273-4. PubMed ID: 9443309
[No Abstract] [Full Text] [Related]
16. Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.
Conway SP; Watson A
Thorax; 1997 Apr; 52 Suppl 2(Suppl 2):S64-8. PubMed ID: 9155855
[No Abstract] [Full Text] [Related]
17. Dornase alfa. A review of pharmacoeconomic and quality-of-life aspects of its use in cystic fibrosis.
Goa KL; Lamb H
Pharmacoeconomics; 1997 Sep; 12(3):409-22. PubMed ID: 10170464
[TBL] [Abstract][Full Text] [Related]
18. Aerosolized deoxyribonuclease for cystic fibrosis.
Med Lett Drugs Ther; 1994 Apr; 36(920):34-5. PubMed ID: 8145672
[No Abstract] [Full Text] [Related]
19. Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial.
Suri R; Metcalfe C; Lees B; Grieve R; Flather M; Normand C; Thompson S; Bush A; Wallis C
Lancet; 2001 Oct; 358(9290):1316-21. PubMed ID: 11684212
[TBL] [Abstract][Full Text] [Related]
20. Efficacy/cost ratio of new therapy.
Fiel SB
Chest; 1995 May; 107(5):1474-5. PubMed ID: 7750356
[No Abstract] [Full Text] [Related]
[Next] [New Search]
